Terms: = Prostate cancer AND POLE, POLE1, 5426, FLJ21434, DKFZp434F222, ENSG00000177084
46 results:
1. Ductal Adenocarcinoma of the prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing.
Zara Rozalen A; Martin JM; Rajendran R; Jain M; Nava VE
Curr Oncol; 2024 Mar; 31(3):1556-1561. PubMed ID: 38534951
[TBL] [Abstract] [Full Text] [Related]
2. SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression.
Liao LX; Zhang M; Xu X; Zhang S; Guo YZ
Front Biosci (Landmark Ed); 2024 Feb; 29(2):69. PubMed ID: 38420826
[TBL] [Abstract] [Full Text] [Related]
3. Treatment intervals and survival for women diagnosed with early breast cancer in Queensland: the Breast cancer Outcomes Study, a population-based cohort study.
Kou K; Aitken JF; Pyke C; Chambers S; Dunn J; Baade PD
Med J Aust; 2023 Nov; 219(9):409-416. PubMed ID: 37667512
[TBL] [Abstract] [Full Text] [Related]
4. Mutation-Attention (MuAt): deep representation learning of somatic mutations for tumour typing and subtyping.
Sanjaya P; Maljanen K; Katainen R; Waszak SM; ; Aaltonen LA; Stegle O; Korbel JO; Pitkänen E
Genome Med; 2023 Jul; 15(1):47. PubMed ID: 37420249
[TBL] [Abstract] [Full Text] [Related]
5. PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas.
Rautajoki KJ; Jaatinen S; Tiihonen AM; Annala M; Vuorinen EM; Kivinen A; Rauhala MJ; Maass KK; Pajtler KW; Yli-Harja O; Helén P; Haapasalo J; Haapasalo H; Zhang W; Nykter M
Sci Rep; 2022 Aug; 12(1):14083. PubMed ID: 35982066
[TBL] [Abstract] [Full Text] [Related]
6. Spindle pole body component 25 and platelet-derived growth factor mediate crosstalk between tumor-associated macrophages and prostate cancer cells.
Cui F; Xu Z; Hu J; Lv Y
Front Immunol; 2022; 13():907636. PubMed ID: 35967419
[TBL] [Abstract] [Full Text] [Related]
7. Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes.
Kumar S U; Balasundaram A; Cathryn R H; Varghese RP; R S; R G; Younes S; Zayed H; Doss C GP
Comput Biol Med; 2022 Sep; 148():105701. PubMed ID: 35753820
[TBL] [Abstract] [Full Text] [Related]
8. Biomarker-driven immunotherapy for precision medicine in prostate cancer.
Ottini A; Sepe P; Beninato T; Claps M; Guadalupi V; Verzoni E; Giannatempo P; Baciarello G; de Braud F; Procopio G
Per Med; 2022 Jan; 19(1):51-66. PubMed ID: 34873959
[TBL] [Abstract] [Full Text] [Related]
9. A pole Splice Site Deletion Detected in a Patient with Biclonal CLL and prostate cancer: A Case Report.
Steiner M; Gassner FJ; Parigger T; Neureiter D; Egle A; Geisberger R; Greil R; Zaborsky N
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502317
[TBL] [Abstract] [Full Text] [Related]
10. Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers.
Ying J; Yang L; Yin JC; Xia G; Xing M; Chen X; Pang J; Wu Y; Bao H; Wu X; Shao Y; Zhu L; Cheng X
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34479923
[TBL] [Abstract] [Full Text] [Related]
11. Solving the enigma of POLD1 p.V295M as a potential cause of increased cancer risk.
Mur P; Magraner-Pardo L; García-Mulero S; Díez-Villanueva A; Del Valle J; Ezquerro E; Lázaro C; Capellá G; Moreno V; Sanz-Pamplona R; Pons T; Valle L
Eur J Hum Genet; 2022 Apr; 30(4):485-489. PubMed ID: 34285382
[TBL] [Abstract] [Full Text] [Related]
12. Intraocular metastasis as a systemic presentation of neuroendocrine differentiation of prostate carcinoma.
Valentín Bravo FJ; Saornil Álvarez MA; García Álvarez C; García Lagarto E; López Castro R
Arch Soc Esp Oftalmol (Engl Ed); 2021 Jun; 96(6):332-336. PubMed ID: 34092288
[TBL] [Abstract] [Full Text] [Related]
13. DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden.
Riggs MJ; Lin N; Wang C; Piecoro DW; Miller RW; Hampton OA; Rao M; Ueland FR; Kolesar JM
PLoS One; 2020; 15(12):e0244558. PubMed ID: 33378353
[TBL] [Abstract] [Full Text] [Related]
14. Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance.
Shin SB; Kim CH; Jang HR; Yim H
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33207738
[TBL] [Abstract] [Full Text] [Related]
15. Renal Cortical
Sarikaya I; Alqallaf A; Sarikaya A
J Nucl Med Technol; 2021 Mar; 49(1):30-33. PubMed ID: 32887764
[No Abstract] [Full Text] [Related]
16. Role of pole and POLD1 in familial cancer.
Mur P; García-Mulero S; Del Valle J; Magraner-Pardo L; Vidal A; Pineda M; Cinnirella G; Martín-Ramos E; Pons T; López-Doriga A; Belhadj S; Feliubadaló L; Munoz-Torres PM; Navarro M; Grau E; Darder E; Llort G; Sanz J; Ramón Y Cajal T; Balmana J; Brunet J; Moreno V; Piulats JM; Matías-Guiu X; Sanz-Pamplona R; Aligué R; Capellá G; Lázaro C; Valle L
Genet Med; 2020 Dec; 22(12):2089-2100. PubMed ID: 32792570
[TBL] [Abstract] [Full Text] [Related]
17. Somatic mutations in the DNA repairome in prostate cancers in African Americans and Caucasians.
Yadav S; Anbalagan M; Baddoo M; Chellamuthu VK; Mukhopadhyay S; Woods C; Jiang W; Moroz K; Flemington EK; Makridakis N
Oncogene; 2020 May; 39(21):4299-4311. PubMed ID: 32300177
[TBL] [Abstract] [Full Text] [Related]
18. Biomarkers for Programmed Death-1 Inhibition in prostate cancer.
Manogue C; Cotogno P; Ledet E; Lewis B; Wyatt AW; Sartor O
Oncologist; 2019 Apr; 24(4):444-448. PubMed ID: 30541755
[TBL] [Abstract] [Full Text] [Related]
19. Spindle pole body component 25 regulates stemness of prostate cancer cells.
Cui F; Tang H; Tan J; Hu J
Aging (Albany NY); 2018 Nov; 10(11):3273-3282. PubMed ID: 30408771
[TBL] [Abstract] [Full Text] [Related]
20. [Relationship between recovery of urinary continence after laparoscopic radical prostatectomy and prostatic volume and intravesical prostatic protursion length].
Zhang F; Xiao CL; Zhang SD; Huang Y; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):621-625. PubMed ID: 30122760
[TBL] [Abstract] [Full Text] [Related]
[Next]
